Suchergebnisse - "Fogari, Elena"

PubPharm (137)

1

Retraction notice to "Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammatin" [European Journal of Pharmaceutical Sciences 51C (2013) 26-33

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2018

von Derosa, G. | Cicero, A. | Carbone, A. | +4

RetractionOf: Eur J Pharm Sci. 2014 Jan 23;51:26-33. - PMID 23999037

2

Retraction notice to "Evaluation of the positive effects on insulin-resistance and β-cell measurements of vildagliptin in addition to metformin in type 2 diabetic patients" [Pharmacol. Res. 73 (2013) 20-26

enthalten in: Pharmacological research | 2017

von Derosa, G. | Ragonesi, P. | Carbone, A. | +4

RetractionOf: Pharmacol Res. 2013 Jul;73:20-6. - PMID 23624419

3

Retraction notice to "Acarbose on insulin resistance after an oral fat load : a double-blind, placebo controlled study"

enthalten in: Journal of diabetes and its complications | 2017

von Derosa, G. | Maffioli, P. | D'Angelo, A. | +3

RetractionOf: J Diabetes Complications. 2011 Jul-Aug;25(4):258-66. - PMID 21367625

4

Retraction Note to : Different Aspects of Sartan + Calcium Antagonist Association Compared to the Single Therapy on Inflammation and Metabolic Parameters in Hypertensive Patients

enthalten in: Inflammation | 2016

von Derosa, G. | Cicero, A. | Carbone, A. | +4

RetractionOf: Derosa G, Cicero AF, Carbone A, Querci F, Fogari E, D'Angelo A, Maffioli P. Inflammation. 2014 Feb;37(1):154-62. - PMID 24018781

5

Retraction notice to "Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapies" : J Am Soc Hypertens 7 (2013) 32-39

enthalten in: Journal of the American Society of Hypertension : JASH | 2015

von Derosa, G. | Cicero, A. | Carbone, A. | +4

RetractionOf: J Am Soc Hypertens. 2013 Jan-Feb;7(1):32-9. - PMID 23321403

6

Retraction notice to "Enalapril/lercanidipine combination on markers of cardiovascular risk : a randomized study": J Am Soc Hypertens 8 (2014) 422-428

enthalten in: Journal of the American Society of Hypertension : JASH | 2015

von Derosa, G. | Bonaventura, A. | Romano, D. | +4

RetractionOf: J Am Soc Hypertens. 2014 Jun;8(6):422-8. - PMID 24836352

7

Retraction Note to: Different Aspects of Sartan + Calcium Antagonist Association Compared to the Single Therapy on Inflammation and Metabolic Parameters in Hypertensive Patients

enthalten in: Inflammation | 2015

von Derosa, G. | Cicero, A. | Carbone, A. | +4

8

Retraction Note to: Different Aspects of Sartan + Calcium Antagonist Association Compared to the Single Therapy on Inflammation and Metabolic Parameters in Hypertensive Patients

enthalten in: Inflammation | 2015

von Derosa, G. | Cicero, A. | Carbone, A. | +4

9

Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients

enthalten in: Metabolism: clinical and experimental | 2014

von Derosa, G. | Bonaventura, A. | Bianchi, L. | +4

10

Enalapril/lercanidipine combination on markers of cardiovascular risk : a randomized study

enthalten in: Journal of the American Society of Hypertension : JASH | 2014

von Derosa, G. | Bonaventura, A. | Romano, D. | +4

RetractionIn: J Am Soc Hypertens. 2015 Oct;9(10):822. - PMID 30153106

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]